20 Cathie Wood Recursion Pharmaceuticals Trades
Cathie Wood acquired 40.2M Recursion Pharmaceuticals shares worth $130M. That's 0.87% of their equity portfolio (32nd largest holding). The investor owns 8.99% of the outstanding Recursion Pharmaceuticals stock. The first Recursion Pharmaceuticals trade was made in Q2 2021. Since then Cathie Wood bought shares fourteen more times and sold shares on five occasions. The investor's estimated purchase price is $354M, resulting in a loss of 63%.
Avg closing price
Price range
Increased shares by 7.8% (+2.9M shares)
Q1 2026
Avg closing price
$4.05
Price range
$2.84
-
$4.96
Increased shares by 11.2% (+3.77M shares)
Q4 2025
Avg closing price
$4.94
Price range
$3.85
-
$6.79
Increased shares by 1.7% (+557k shares)
Q3 2025
Avg closing price
$5.24
Price range
$4.52
-
$6.54
Sold 5.2% shares (-1.83M shares)
Q2 2025
Avg closing price
$4.91
Price range
$3.97
-
$5.84
Increased shares by 7.6% (+2.47M shares)
Q1 2025
Avg closing price
$7.33
Price range
$5.29
-
$10.87
Sold 1.3% shares (-423k shares)
Q4 2024
Avg closing price
$6.72
Price range
$5.70
-
$8.27
Increased shares by 16.4% (+4.63M shares)
Q3 2024
Avg closing price
$7.17
Price range
$5.92
-
$8.60
Increased shares by 14.5% (+3.56M shares)
Q2 2024
Avg closing price
$8.72
Price range
$7.35
-
$10.05
Increased shares by 19.0% (+3.93M shares)
Q1 2024
Avg closing price
$11.14
Price range
$9.13
-
$15.52
Increased shares by 200.4% (+13.8M shares)
Q4 2023
Avg closing price
$7.13
Price range
$5.09
-
$10.79
Increased shares by 45.1% (+2.14M shares)
Q3 2023
Avg closing price
$9.98
Price range
$6.59
-
$15.86
Increased shares by 32.5% (+1.16M shares)
Q2 2023
Avg closing price
$7.00
Price range
$4.56
-
$9.94
Increased shares by 15.4% (+477k shares)
Q1 2023
Avg closing price
$7.93
Price range
$6.42
-
$9.64
Sold 7.7% shares (-260k shares)
Q4 2022
Avg closing price
$9.81
Price range
$7.16
-
$12.70
Increased shares by 23.0% (+628k shares)
Q3 2022
Avg closing price
$10.13
Price range
$7.83
-
$13.60
Sold 3.4% shares (-95.1k shares)
Q2 2022
Avg closing price
$6.69
Price range
$5.04
-
$9.26
Increased shares by 26.7% (+595k shares)
Q1 2022
Avg closing price
$10.63
Price range
$6.16
-
$18.03
Sold 13.9% shares (-362k shares)
Q4 2021
Avg closing price
$18.82
Price range
$16.14
-
$21.86
Increased shares by 9.0% (+215k shares)
Q3 2021
Avg closing price
$28.34
Price range
$19.03
-
$41.33
New holding (+2.38M shares)
Q2 2021
Avg closing price
$29.60
Price range
$21.06
-
$37.42
News about Recursion Pharmaceuticals Inc - Ordinary Shares - Class A and Cathie Wood
Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock
Recursion Pharmaceuticals (NASDAQ: RXRX ) is one of the high-flying stocks gaining focus in today’s market. Indeed, shares of RXRX stock are rocketing more t...
Cathie Wood Just Made a Big Bet on Recursion Pharmaceuticals Stock. Will It Pay Off?
Cathie Wood just gave the company a huge vote of confidence.